Every year, millions suffer from conditions that modern medicine struggles to address. Of the many patients in need of an organ transplant, 90% never receive one. Around 240 million people live with rare genetic diseases, the vast majority of which lack effective treatments. Poor diets contribute
It all started with a tweet. In 2019, during his first term as U.S. president, Donald Trump shared a surveillance photo of an Iranian missile site following an explosion. The unusually high quality of the image, combined with its angle and analysis by amateur satellite trackers, led experts to a
All American presidents eventually reach a point where they wish they had more power. Most, however, accept that Congress and the courts play an essential role in governance. Donald Trump, in contrast, appears to interpret Article II of the Constitution as a carte blanche for presidential
The annual meetings of the American Association for the Advancement of Science (AAAS) have long served as a platform for researchers to showcase cutting-edge innovations. At the latest gathering in Boston, held from February 13th to 15th, attendees explored a broad array of scientific
Modern competitive running entered a new era in 2016 when Nike introduced a prototype trainer to elite athletes. The shoes, which were designed to resemble Nike’s Zoom Streak 6 but with a groundbreaking new sole, quickly made their mark. At the Rio Olympics that year, athletes wearing the
At a high-profile summit in Paris on February 10th and 11th, tech leaders competed to make the boldest proclamations about artificial intelligence. "AI will be the most profound shift of our lifetimes," declared Sundar Pichai, CEO of Alphabet. Dario Amodei, chief executive of Anthropic,
A towering statue of Mao Zedong still stands near the entrance of Zhejiang University (Zhe Da), surveying the transformation of Hangzhou, an eastern city 175 km southwest of Shanghai. While such statues now seem out of place across China, they appear particularly anachronistic here, given the
In the world of pharmaceuticals, blockbuster drugs like Keytruda, a cancer immunotherapy treatment, dominate the industry. Since its 2014 launch, Keytruda has generated over $130 billion in revenue for its American manufacturer, Merck, including $29.5 billion in 2023 alone. Yet, in September 2023,